Tianjin, China

Weiwei Zhao


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Weiwei Zhao in Affinity Peptide Library Construction

Introduction

Weiwei Zhao is a notable inventor based in Tianjin, China. He has made significant contributions to the field of biochemistry, particularly in the development of affinity peptide libraries. His innovative work focuses on enhancing the purification processes of immunoglobulin G (IgG), which is crucial for various biomedical applications.

Latest Patents

Weiwei Zhao holds a patent titled "Method for constructing a novel affinity peptide library for binding immunoglobulin G based on a protein affinity model of protein A." This patent describes an affinity ligand peptide library of IgG constructed using a Protein A affinity model. The method involves utilizing the Molecular Mechanics—Poisson-Boltzmann surface area (MM/PBSA) approach to identify high-affinity hot spots of Protein A for human IgG. The resulting affinity peptide library includes heptapeptide and octapeptide structural modes, which are further refined through molecular docking and dynamics simulations. Ultimately, the identified affinity peptide ligands effectively purify IgG using affinity chromatography.

Career Highlights

Weiwei Zhao is affiliated with Tianjin University, where he continues to advance his research in peptide library construction and protein interactions. His work has garnered attention for its potential applications in therapeutic and diagnostic fields.

Collaborations

Weiwei Zhao collaborates with esteemed colleagues, including Yan Sun and Fufeng Liu, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their scientific investigations.

Conclusion

Weiwei Zhao's innovative approach to constructing affinity peptide libraries represents a significant advancement in the field of biochemistry. His contributions are poised to improve the efficiency of IgG purification processes, thereby benefiting various biomedical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…